FDA Label for Aripiprazole
View Indications, Usage & Precautions
Aripiprazole Product Label
The following document was submitted to the FDA by the labeler of this product Square Pharmaceuticals Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
NDC 76483-100-00
Aripiprazole Orally Disintegrating Tablets, USP 10 mg
30 Tablets
Rx Only
NDC 76483-100-01
Aripiprazole Orally Disintegrating Tablets, USP 10 mg
60 Tablets
Rx Only
NDC 76483-100-02
Aripiprazole Orally Disintegrating Tablets, USP 10 mg
90 Tablets
Rx Only
NDC 76483-100-03
Aripiprazole Orally Disintegrating Tablets, USP 10 mg
120 Tablets
Rx Only
NDC 76483-101-00
Aripiprazole Orally Disintegrating Tablets, USP 15 mg
30 Tablets
Rx Only
NDC 76483-101-01
Aripiprazole Orally Disintegrating Tablets, USP 15 mg
60 Tablets
Rx Only
NDC 76483-101-02
Aripiprazole Orally Disintegrating Tablets, USP 15 mg
90 Tablets
Rx Only
NDC 76483-101-03
Aripiprazole Orally Disintegrating Tablets, USP 15 mg
120 Tablets
Rx Only
NDC 76483-102-00
Aripiprazole Orally Disintegrating Tablets, USP 20 mg
30 Tablets
Rx Only
NDC 76483-102-01
Aripiprazole Orally Disintegrating Tablets, USP 20 mg
60 Tablets
Rx Only
NDC 76483-102-02
Aripiprazole Orally Disintegrating Tablets, USP 20 mg
90 Tablets
Rx Only
NDC 76483-102-03
Aripiprazole Orally Disintegrating Tablets, USP 20 mg
120 Tablets
Rx Only
NDC 76483-103-00
Aripiprazole Orally Disintegrating Tablets, USP 30 mg
30 Tablets
Rx Only
NDC 76483-103-01
Aripiprazole Orally Disintegrating Tablets, USP 30 mg
60 Tablets
Rx Only
NDC 76483-103-02
Aripiprazole Orally Disintegrating Tablets, USP 30 mg
90 Tablets
Rx Only
NDC 76483-103-03
Aripiprazole Orally Disintegrating Tablets, USP 30 mg
120 Tablets
Rx Only
* Please review the disclaimer below.